Αρχική World News 2-Time Cancer Survivor Warns Against Breast Implants After 4 Doctors Missed Her...

2-Time Cancer Survivor Warns Against Breast Implants After 4 Doctors Missed Her BIA-ALCL

Joanne Chaplin-Schuman, a 70-something artist and model, is a two-time cancer survivor who considers herself lucky to be alive. But her life never would have been threatened the second time if it weren’t for the breast implants she got after her first round of cancer. It took switching doctors four times to get diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), a type of immune cancer caused by breast implants, usually textured ones. Now she’s on a mission to warn others against this rare cancer that doctors often miss.Joanne’s story started 20 years ago, when she was diagnosed with breast cancer. As part of her treatment, she had a double mastectomy followed by reconstruction with textured breast implants. Over the years, she’s had four different sets of implants as each one wore out, but in all that time and with all those procedures, no one ever discussed the risk of cancer or other complications with her.Photo: YouTube/azfamily powered by 3TV & CBS5AZ
But after about two decades of having implants, Joanne began to experience severe pain and swelling in her right breast and knew something was wrong.“I was having excruciating pain in my right breast. It happened suddenly, and it only lasted like a minute. It was hard to breathe it was so bad,” Joanne remembers. “This breast over here looked fine in the mirror, and this one was higher up and bigger.”Photo: YouTube/azfamily powered by 3TV & CBS5AZFirst, Joanne went to see her family doctor, who could do nothing for her. “She didn’t really know what she was looking at, nor did I,” says Joanne.So she went to a plastic surgeon, but that individual also turned out to be of little help. “He kept staring at it, like he’s never seen anything [like it] before.”
Photo: YouTube/azfamily powered by 3TV & CBS5AZJoanne then moved on to a radiologist and a surgeon. She was advised to have chemotherapy and radiation therapy for her cancer, even though it wasn’t entirely understood what the cancer was. She didn’t like that answer either, so, on the recommendation of the surgeon, she finally saw a fifth doctor, who ended up being the one she needed.“He said, ‘I’m going to take care of you. We’re going to remove the whole thing, you don’t need radiation or chemotherapy, and you’re going to be fine.’”Joanne had her implants removed and is now cancer-free. She believes that she had at least one set of implants with a textured shell somewhere along the way that were likely the cause of her cancer, and she also firmly believes that there are other women like her out there who are having symptoms of BIA-ALCL but know nothing about it, nor do their doctors.
Photo: YouTube/azfamily powered by 3TV & CBS5AZOnly recently has the cancer link come to light, leading to several bans of textured implants in European countries. The FDA looked into the issue, which included hundreds of cases and several deaths in the U.S. alone but decided the problem wasn’t big enough to warrant banning textured implants nationwide.Joanne was understandably shocked when the FDA decided not to ban textured implants in the U.S., as were many other BIA-ALCL survivors and their families. But she was more than just surprised. “I was horrified,” she says.Luckily, BIA-ALCL is still a fairly rare cancer and is curable in most cases by simply surgically removing the implants and the surrounding scar tissue where the cancer originates. But many doctors don’t know to look for BIA-ALCL and may not be able to diagnose the disease when it’s right in front of their faces. Awareness, Joanne says, is vitally important, and the government shouldn’t be downplaying the possibility of cancer from textured breast implants.“Even though it’s a very rare cancer, it happened to me. It can happen to you. It can happen to anyone,” says Joanne.Learn more about Joanne’s story in the video below.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

The IGCCCG Update Model Allows Improved and More Granular Individual Prognostic Assessment in Metastatic Non-Seminomatous Germ Cell Tumours

A new web-based calculator based on the results of the International Germ Cell Cancer Collaborative Group (IGCCCG) Update analysis allows improved and more granular individual prognostic...

How Sharing My Story Helps Me Cope With an Advanced Brain Tumor Diagnosis

Tom Freeman is an audio technology professional working in Silicon Valley. At night, he is a music and video producer who works with various...

Percentage of Cancer Patients Who Are Eligible for and Respond to Genome-Targeted Therapy Modestly Increased Over Time

Dr. Alyson Haslam of the Department of Epidemiology and Biostatistics, University of California San Francisco in San Francisco, CA, US and colleagues reported on...

How to Find an Oncologist Who’s an LGBTQ+ Ally: An Expert Q&A

Charles Kamen, PhD, MPH, is a clinical psychologist and assistant professor at the University of Rochester Medical Center. Dr. Kamen has a strong background...

Sharing Energy

Do you have a favorite flower? It is very difficult for me to choose a favorite, for there is such a vast array of...

FDA Approves BCMA-Targeted CAR T-Cell Therapy for Multiple Myeloma

April 14, 2021, by NCI Staff Manufactured CAR T cells ready for infusion into a patient. Credit: Penn Medicine A type of immunotherapy called CAR T-cell therapy...